TY - JOUR T1 - A triangulated study on non-pharmacological management of Alzheimer’s disease in Mauritius JF - medRxiv DO - 10.1101/2021.04.27.21255997 SP - 2021.04.27.21255997 AU - Geeta Devi Dorkhy AU - Goorah Smita AU - Sorefan Ameenah Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/20/2021.04.27.21255997.abstract N2 - Dementia is a neurodegenerative disease, with more than 50 million people worldwide. Nearly 60% are living in the low and middle-income countries [1]. Mauritius has a rising population of elderly people, of 7.5% above 65 years [2]. Currently 14,000 people with Alzheimer’s disease (AD), show very modest improvements with pharmacological therapies. Alzheimer’s Association in Mauritius, the only NGO, which assist person with AD and offer multiple non-pharmacological therapies (NPT).Objectives The main study aim is to find the outcomes of NPT in the management of AD and the correlation of data in mixed studies.Setting The participants were recruited from Alzheimer’s Association Mauritius, the only NGO. The center provides NPT such as cognitive training, reminiscence therapy, socialization and group interactive games.Primary and secondary outcome measures Both quantitative and qualitative studies were triangulated to find similarities (matched) and unsimilar (unmatched) results.Result Quantitative data (n=42) analysis showed a direct statistical decline in higher function (IADL) with respect to decreasing cognition. Qualitative study (n=20) emerged with 7 main themes among which ‘dependency in AD’ was a main theme. Mixed study results showed 6 out of 7 main themes were linked to/ matching to statistical results after triangulation.Conclusion NPT is an effective tool in the management of AD in Mauritius. Triangulated studies allowed in depth analysis of the patient.Strengths and limitations of the studyMixed study provides in depth analysisData speaks for itself, it is lived experienceMixed studies complement each otherHowever, it is a time consuming processParticipant unwillingness to participateCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialEthical committee the Ministry of Health and Quality Of Life, Mauritius and the Consultant, Ministry of Social Security, National Solidarity & Reforms Institutions, MauritiusFunding Statementno funding providedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical committee the Ministry of Health and Quality Of Life, Mauritius and the Consultant, Ministry of Social Security, National Solidarity & Reforms Institutions, MauritiusAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data available in the manuscript may be provided upon request https://www.alzheimerdisease.com https://www.alzheiemrmanagement.com ER -